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Abstract
With the widespread presence of sleep disorders in the United States, especially
insomnia, it is pertinent to investigate beliefs that patients have about insomnia, symptom
severity, and treatment acceptability in order to assess patients’ motivation for behavioral
change. Participants in this archival study were thirty-one patients seeking help for sleeprelated issues, whom were primarily from a Midwestern metropolitan area. Patients had
completed pre-treatment measures that assessed insomnia symptoms, outcomes,
treatment acceptability, and willingness to change and one post-treatment measure
assessing insomnia outcomes. Because the purpose of the present study was to examine
whether these variables predict patient improvement (higher scores on the post-treatment
measure), a linear regression was used to analyze the data. Results indicated that pretreatment insomnia outcomes, symptoms, change, and treatment acceptability did not
predict higher scores of patient improvement. Because there has not been a significant
amount of research conducted on the topic of predictors of insomnia treatment outcome
and the fact that novel outcome measures were used, future research should focus on
developing more psychometrically sound outcomes measures.
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Symptom Severity, Treatment Acceptability, and Motivational Predictors Related to
Patient Improvement for Insomnia
In the United States today, sleep disorders and exiguous sleep quality is becoming
a national pandemic. According to the Center for Disease Control (CDC), 50 to 70
million Americans suffer from sleep disorders that cause wakefulness, such as insomnia.
Sleep disorders like insomnia can create issues with everyday functioning (“Insufficient
sleep”, 2014). For insomnia specifically, the National Sleep Foundation reports that
almost 50% of the American population experiences insomnia every now and again,
while 22% of the population suffers from insomnia almost every day of the week. Within
the U.S. population, “females are 1.3 times more likely to report insomnia than males.
Also, those over the age of 65 are 1.5 times more likely to complain of insomnia than
younger people. Divorced, widowed and separated people report more insomnia” (“Sleep
aids”, 2013).
While examining the symptomatic spectrum of insomnia effects, areas of life
commonly disrupted by insomnia can range anywhere from difficulty concentrating and
trouble with remembering things to more hazardous consequences such as having driving
skills affected or struggling to perform occupational duties. Also, those who experience
inadequate sleep are more apt to be affected by other abiding syndromes such as
“hypertension, diabetes, depression, and obesity, as well as from cancer, increased
mortality, and reduced quality of life and productivity” (“Insufficient sleep”, 2014). Not
only does insomnia cause problems for each individual suffering from the disorder, but
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the United States also suffers from insomnia as a whole, economically speaking. The
most recent yearly update on the direct costs of insomnia’s effect on the United States’
population equaled more than 14 billion dollars. These costs include treatment for
insomnia and other healthcare costs, such as doctors’ visits and hospital stays. Lastly,
besides the direct cost of insomnia symptoms to the U.S. healthcare system, the indirect
costs of insomnia reach up to 35 billion dollars annually and the cost of productivity lost
to insomnia alone is approximately equal to 18 billion dollars a year (National Sleep
Foundation, 2013).
With the widespread presence of sleep disorders in the United States, especially
insomnia, it is pertinent to investigate beliefs that patients have about insomnia, symptom
severity, and treatment acceptability in order to assess patients’ motivation for behavioral
change that can lead to overall improvement. Recent empirical literature has examined
these very topics. For instance, Montserrat Sánchez-Ortuño and Edinger (2010)
conducted a study that investigated the relationships between patients’ maladaptive
beliefs about insomnia, their presenting symptoms, and treatment progression. This study
used a sample of over 250 insomnia patients and had the patients complete the
Dysfunctional Beliefs about Sleep questionnaire (DBAS-16). After completing this scale,
patients also completed an Insomnia Symptoms Questionnaire (ISQ), the Stanford
Sleepiness Scale (SSS), the Beck Depression Inventory (BDI), the State-Trait Anxiety
Inventory (STAI), and, lastly, a sleep history questionnaire.
Overall, the results from the DBAS-16 were aggregated into four distinct
subgroups, according to the patients’ scores on the questionnaire itself. These subgroups
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were labeled as the “Worried and Medication-Biased” cluster, the “Low Endorsement”
cluster, the “Mild Sleep Worries” cluster, and the “Worried and Symptom-Focused”
cluster. Out of these subgroups, Montserrat Sánchez-Ortuño and Edinger (2010) noted
that the “Low Endorsement” cluster held beliefs about sleep-related symptoms that would
constitute an average individual’s beliefs with relatively low sleeping problems
altogether. In general, two of the subgroups showed elevated scores in relation to
insomnia symptoms, while the others were more representative of a “normal” sample
(Montserrat Sánchez-Ortuño and Edinger, 2010). Subsequent to the completion of all of
the questionnaires, the authors of the study conducted a Cognitive-Behavioral Therapy
(CBT) program for the participants, with the number of treatment sessions spanning over
one to eight weeks in length. All in all, the results of the study demonstrated that because
of the differing and negative beliefs about insomnia amongst participants, one standard
type of CBT treatment administration does not produce adequate treatment outcomes.
These results suggest that CBT programs for insomnia should be specifically tailored to
the individual in regards to their beliefs about sleep and their beliefs about treatment
methods for overcoming insomnia (Montserrat Sánchez-Ortuño and Edinger, 2010).
Another study conducted by Sidani, Miranda, Epstein, Bootzin, Cousins, and
Moritz (2009) examined individuals’ personal beliefs about insomnia. Although similar
in nature to the study authored by Montserrat Sánchez-Ortuño and Edinger (2010), this
study specifically analyzed the relationship between personal beliefs, treatment
acceptability, and preferences for behavioral interventions. Sidani, et al.’s (2009) analysis
used data from over 400 individuals with insomnia that participated in one of two clinical
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trials that targeted treatment options for insomnia. During these clinical trials,
participants were presented with treatment options for insomnia and were asked to rank
these treatment options according to the acceptability of such methods and their
preferences for the treatment options prescribed to them. The treatment options that
participants were given included sleep education and hygiene or a multi-component
intervention that included the education component, but also included stimulus control
features and sleep restriction therapy to establish a regulated sleep-wake schedule. In
addition to preferences and treatment acceptability, demographic, clinical, and personal
belief information was recorded for each participant as well. This information was
recorded in order to prevent confounding effects for each participant’s preferences for
insomnia treatment.
Comprehensibly, the results of Sidani, et al.’s (2009) investigation of beliefs
about insomnia demonstrated that participants with persistent or chronic insomnia
symptoms preferred behavioral interventions for the treatment of insomnia because of its
lack of side effects and hope for long-term insomnia maintenance. Although behavioral
interventions were preferred by a few patients, they would choose the most convenient
method of treatment as the most preferable treatment, regardless of other types of
treatment methods available, . Also, as the current study plans to expound upon treatment
acceptability, Sidani’s (2009) findings display a predictive relationship between patients’
acceptability and beliefs about treatment and their preferences for treatment in general.
Although the patients’ acceptability of certain treatment predicted and helped to guide
their preferences toward certain treatments, the results of the study indicated that there
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was not a relationship between the patients’ personal beliefs about insomnia, the
condition itself, and their treatment preferences.
When continuing to evaluate the impact that insomnia has on a given population,
it is imperative to measure patient preferences and acceptability of insomnia treatment
methods in conjunction with their history of insomnia symptoms. As highlighted by
Epstein, et al. (2012), specific methods of insomnia treatment, such as Cognitive
Behavioral Therapy for Insomnia (CBT-I), have demonstrated to be highly efficacious in
modern empirical literature, however, it is important to note how crucial patient
motivation and willingness to accept treatment play apart in overall patient improvement.
Treatment programs like CBT-I are usually very time-consuming and require patients to
put forth a great deal of effort. If patients are not motivated enough and do not “have their
hearts” in the treatment being provided, whether or not the method of treatment is
“proven” to be effective, then the ultimate outcome for patients could be disappointing, at
best (Epstein, 2012).
Another interesting finding to consider from Eptein’s (2012) study was the fact
that clinicians and patients held significantly different attitudes and views towards the
acceptability and preference of certain insomnia treatment. For instance, as mentioned
above, many patients, especially in the case of this study with Veterans, participants felt
that medications were the most acceptable form of treatment and were the most preferred
method for symptom improvement. However, although providers rated medication highly
as well, they differed in that they viewed sleep restriction practices and stimulus control
therapies as better alternatives for overall insomnia improvement due to their empirical
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effectiveness. Veterans tended to shy away from these methods of treatment due to their
time-consuming nature and required effort. Both the clinicians and Veterans agreed that
medication could create negative long-term effects, such as chemical reliance on the
medication. Overall, the study found that most patients found the treatments they
preferred the most to be the treatments that deemed as most acceptable.
When patient improvement is assessed in terms of treatment acceptability and
willingness to change, some researchers have examined how patients perceived and
viewed their own insomnia symptom improvement after a structured six-component CBT
treatment program, which was the case in Vincent, Penner, and Lewycky’s (2006)
groundbreaking study. Other studies have merely focused on the effectiveness of
behavioral treatments or the preference levels and motivational factors related to
treatment acceptability. However, very few have investigated how patients feel about
their improvement, which could provide important information as to how and why
patients felt that their symptoms improved throughout their treatment process.
Vincent, Penner, and Lewycyk (2006) demonstrated that certain aspects or
characteristics of sleep itself are predictors of patients’ perceived symptom improvement.
The Clinical Global Improvement Scale (CGI) was utilized during the course of this
study and researchers allocated patient responses into two different categories of
“primary” and “secondary” measures of sleep characteristics. Such primary measures
include sleep characteristics of: sleep quality, sleep duration, and sleep efficiency. On the
other hand, secondary measures included characteristics like daytime impairment (due to
insomnia symptoms) and mood (Vincent, Penner, & Lewycyk, 2006). In general, it was
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found that daytime impairment predicted better-perceived improvement and mood
predicted a dearth of perceived improvement for secondary measures. For primary
measures, sleep quality and duration were the strongest predictors of improvement. Due
to the significant findings of prediction for the primary measures, understanding patients’
treatment acceptability ratings and motivations for treatment may help to better
individually tailor a treatment program to best suit patients, rather than using the standard
CBT-I protocol for all patients regardless of their clinical presentation.
Purpose of the Current Study
Considering the research that has been conducted in this area of sleep psychology,
the purpose of the present study was to determine whether the variables of insomnia
symptoms, treatment acceptability, and behavior change factors affect patient
improvement. Specifically, it was hypothesized that insomnia patients with more severe
symptoms, that had high ratings of treatment acceptability across a wide array of
treatments, and were motivated for changing their behavior would show greater
improvements in insomnia symptoms at post-treatment. Specifically, improvement would
involve endorsing a greater number of nights per week receiving enough quality sleep
according to the post-treatment follow-up Insomnia Outcomes Scale used. Also, it was
hypothesized that patients who improved over the course of the study would endorse a
greater number of days per week that they were happy with how they felt and endorse
fewer number of days per week in which they felt tired or fatigued.
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Method
Participants
There were 85 participants recruited for the present study at sleep centers in a
large metropolitan area in the Midwestern United States. Other demographic information
was not collected from participants to protect their privacy and participants were simply
assigned random identification number. Participants were recruited during an initial
appointment with a sleep psychologist to address ongoing symptoms of potential sleep
disorders. Participants then attended a series of appointments with the sleep psychologist
as prescribed by their treatment plan. At the conclusion of the study, a total of 31 patients
were included in the analysis because the study required a measure of post-treatment
symptoms and 54 of the original patients recruited did not complete the post-treatment
insomnia symptoms measure.
Measures
Insomnia outcomes scale. Dr. Donald Townsend at Fairview Health Systems in
Minnesota developed the Insomnia Outcomes Scale. This scale includes four questions
regarding the severity of insomnia symptoms in terms of how many nights per week the
patient got enough sleep, how many nights per week the patient slept well, how many
days per week the patient felt tired or fatigued, and how many days per week the patient
was happy with how he or she felt. All of these items had a Likert-style response scale
ranging from “1 or less” to “7” and referred to the nights or days per week that patients
experienced symptoms within the past month (see Appendix A). One of the items on the
Insomnia Outcomes Scale was recoded due to negative wording (“In the past month, how
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many days a week have you felt tired or fatigued?”). Because the Insomnia Outcomes
Scale is a newly developed measure of insomnia-related consequences, psychometric
properties of the scale have not been tested. The present researcher conducted a
preliminary reliability analysis and found the reliability of the questionnaire to be α = .78.
Treatment acceptability scale. The Treatment Acceptability Scale was also
developed for clinical and research purposes by Dr. Donald Townsend. This measure
consists of ten items describing ten different methods of insomnia treatment. These
treatment methods include behavior modification treatment methods (relaxation CD,
changing my sleep habits, reading a book about sleep, stop using caffeine, alcohol, and
tobacco products, and getting out of bed if the patient cannot sleep), medication treatment
(prescription medication and over-the-counter medication), and medical expert
professional treatment (talking to my primary care physician, talking with a
counselor/therapist, and seeing a sleep therapist). Items on the treatment acceptability
scale have a Likert-style response scale with responses ranging from “Not effective at
all” to “Highly effective” (see Appendix B). A reliability analysis was also conducted for
this measure, with α = .80.
Change scale. The Change Scale was also developed by sleep psychologist Dr.
Donald Townsend for clinical and research purposes. This scale includes eleven items on
a 1 to 5 Likert scale with responses ranging from Strongly Agree (1) to Strongly Disagree
(5). Items on the scale captured patients’ motivation to change behaviorally in regards to
their insomnia symptoms and personal characteristics (see Appendix C for specific scale
items). Five of the items on the Change Scale were recoded in order to account for their
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negative wording (“My sleep problems are not that important.”, “I’ve given up on trying
to improve my sleep problems.”, “It is very difficult for me to make changes in my life.”,
“I don’t think there is anything I can do to improve my sleep problems.”, and “Most of
what happens to me is bad luck.”). Because the Change Scale is a newly developed
measure and has not yet been psychometrically tested, a reliability analysis of the scale
was conducted, demonstrating results of α = .46.
Procedure
Patients whom presented with or complained of symptoms of insomnia were
asked if they would like to participate in the current study at their first appointment with a
sleep psychologist. Data collected for the current study was archival data that was
originally used to assess the use of an insomnia outcomes scale. In order to participate in
the study, patients had to give consent for participation in the study and for treatment by
signing a detailed consent form (see Appendix D). Patients also received a recruitment
flyer at the time of consent in order to provide an outline of the requirements of the study
(see Appendix E). Participants who had consented to participating in the study were
subsequently given the Insomnia Outcomes Scale, the Treatment Acceptability Scale, and
the Change scale to complete. Responses to each of these questionnaires were recorded
and organized into a Microsoft Excel spreadsheet and then were later transferred to the
Statistical Package for the Social Sciences (SPSS) for further data analysis. Data that was
missing in SPSS was labeled as missing with the response, “999”.
Six months after the initial appointment when the original questionnaires were
completed, participants were mailed another copy of the Insomnia Outcomes Scale to
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complete as a post-treatment follow-up questionnaire. If patients did not return the
follow-up Insomnia Outcomes Scale to the sleep clinic via the postage-paid envelope
given to them within a month of receiving the questionnaire, then a second copy of the
questionnaire was sent. When patients did respond either of the copies of the follow-up
questionnaire that was sent, a last reminder was given to patients of whom patients were
contacted via telephone. If a patient responded on the telephone, the follow-up Insomnia
Outcomes Measure was administered to the patient during the telephone call, as was
stipulated by a standardized procedure of greeting the patients, administering the
questionnaire, and finally, concluding the call by welcoming any patient comments about
their experiences with treatment for insomnia.
Once data was gathered from the follow-up outcomes measure, it was entered into
the SPSS database. However, as mentioned previously, data from 54 of the participants
was excluded from data analysis because they did not complete the post-treatment
Insomnia Outcomes Scale measure.
Data Analysis
Because the hypothesis of this study proposes that responses on the initial
Insomnia Outcomes Scale, Treatment Acceptability Scale, and the Change Scale predict
overall patient improvement (as indicated by higher levels of responding on the posttreatment follow-up Insomnia Outcomes Scale), a multiple linear regression analysis
approach was used to test the hypothesis. For data analysis purposes, the Treatment
Acceptability Scale was divided into three groups based upon the item type, resulting in
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three treatment acceptability variables: “Medication Treatment”, “Behavior Modification
Treatment”, and “Medical Expert Professional Treatment”.
Results
With the data remaining from the 31 participants who completed the follow-up
Insomnia Outcomes Scale, a multiple linear regression was conducted. The initial
Insomnia Outcomes Scale, the Treatment Acceptability Scale variables (“Medication
Treatment”, “Behavior Modification Treatment”, and “Medical Expert Professional
Treatment”), and the Change Scale were used as predictors in the regression model, while
the follow-up Insomnia Outcomes Scale was used as the criterion. To conduct the
regression analysis, the pre-treatment variables (the four items on the questionnaire,
utilizing the recoded item) of the Insomnia Outcomes Scale were combined together to
compute a new variable, as were the post-treatment variables (the four items on the
questionnaire, utilizing the recoded item) of the follow-up Insomnia Outcomes Scale in
order to create a measure of both pre- and post-treatment outcomes. Similarly, the eleven
variables, or items, on the Change Scale (utilizing the five recoded items) were combined
to create a new variable of the scale’s responses as a whole.
The results of the multiple linear regression analysis demonstrated that the overall
model of the study’s hypothesis was non-significant, where F(5, 26) = 1.27, p > .05 (see
Figure 1 in Appendix F). Because the overall model was non-significant, the individual
predictors were non-significant as well (see Table 1 and Table 2 in Appendix F).
However, the pre-treatment Insomnia Outcomes Scale was marginally significant at β =
.42, p = .06.
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In addition to the multiple linear regression, a one-way repeated measures
ANOVA was conducted to assess the differences between the pre-treatment insomnia
outcomes measure and the post-treatment insomnia outcomes measure. This analysis was
conducted because the results within the regression model for prediction between these
two variables were marginally significant. The results of this analysis demonstrated nonsignificant results, F(13, 27) = 1.01, p > .05. This result indicates that there are no
significant differences between responding on the pre- and post-treatment insomnia
outcomes measures, suggesting that the functioning of patients in regards to their
insomnia symptoms did not significantly improve.
Also, it is imperative to note the variance in responding on the various measures
used for this study as well. For the pre-treatment insomnia outcomes measure (M = 9.32,
SD = 5.33), the post-treatment insomnia outcomes measure (M = 17.35, SD = 6.90), the
medication treatment acceptability subscale (M = 35.18, SD = 178.88), the medical expert
professional treatment acceptability subscale (M = 35.18, SD = 178.88), and the change
scale (M = 33.30, SD = 3.57), the variance amongst the data of responding was relatively
large, as indicated by higher standard deviation scores. This indicates that the data for
these measures does not accurately represent the mean. However, the behavior
modification treatment acceptability scale (M = 2.34, SD = 0.79) had lower variance in
responding and includes data that more accurately represents the mean. This result could
suggest that behavior modification treatments were perceived as more acceptable to
participants of this study, compared to other treatment options.
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Discussion
Although previous research in the area of sleep psychology has demonstrated that
patient improvement is dependent on an individual’s insomnia symptoms, willingness to
change, and treatment acceptability, the present study failed to demonstrate similar
results. In this case, insomnia outcomes and symptoms, willingness to change, and
treatment acceptability did not predict patient improvement.
The non-significant findings of this study can be understood in terms of
limitations of the study’s design and use of measures with unknown psychometric
properties. One of the greatest limitations of this study concerns the small sample size.
Original recruitment efforts at the sleep clinic resulted in an initial pool of 86
participants. But, with the low response rate of participants for the post-treatment
Insomnia Outcomes Scale at 36%, only 31 participants were included in the study.
According to Hager, Wilson, Pollak, and Rooney (2003), the acceptable rate of survey
responses for a study varies within different fields of research, ranging anywhere from as
low as 50% to as high as 75%. Some researchers even suggest that response rates below
than 60% are atrocious (Schutt, 1999). By these standards the response rate for the
current study was relatively low, which calls into question whether a representative
sample was obtained for this study.
In addition, response bias may pose a limitation in that certain individuals are
simply more likely to respond to mailed surveys than others, which also limits the
representativeness of the sample. Lastly, although the post-treatment outcomes measure
was sent to participants twice and a standardized phone call was used to follow up,
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variables such as not having the envelopes addressed using handwritten words, not
having a real stamp on the envelope (instead of a pre-paid business reply postage), or not
having any monetary incentive for the completion of the questionnaire could have
negatively affected the response rate (Hager, et al., 2003).
Besides addressing the importance of the study’s sample size in terms of
acceptable response rates, it is vital to address the role of sample size and how it relates to
the power of this study. With such a low sample size, the power of the current study is
only at a 0.71 level (calculated using the statistical software, G*Power). In most cases, a
.80 level of statistical power is deemed appropriate for a study (Field, 2013). Because
sample size affects the level of power for data analyses (because it is difficult to discover
effect sizes within smaller populations), a lower level of power can impact significance
levels in deleterious ways, such as failing to detect effects that are present.
Another limitation of the current study includes the significance of the pretreatment Insomnia Outcomes Scale in the regression analysis. Although the overall
model for the regression used in this study was found to be non-significant, the
marginally significant result for the pre-treatment Insomnia Outcomes Scale potentially
indicates that pre-treatment functioning of patients predicts overall post-treatment
improvement. For example, higher ratings on the pre-treatment Insomnia Outcomes Scale
would predict lower endorsement ratings on the post-treatment Insomnia Outcomes
Scale. However, the results of the one-way ANOVA test in this study demonstrate that
there were no significant differences between these two variables. It is possible that the
marginally significant results occurred due to chance. With that being said, one factor
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that could potentially influence the significance of this outcome is the small sample size
in this study. Future studies with larger samples may find significant relationships
between pre-treatment and post-treatment insomnia outcomes.
The lack of significant results could also possibly be explained by the
psychometric properties of the scales and questionnaires used. For instance, because the
three measures used in the study were recently developed, they have yet to be
psychometrically tested. As mentioned previously, the reliability of the scales were
analyzed, however one measure, the Change Scale, had an unacceptable Cronbach’s
alpha value of α = .46. Because the reliability for this measure was low, there should be
caution when using it to evaluate patient improvement for individuals experiencing
insomnia. Also, because there is a lack of psychometric data available for these three
scales, it is highly recommended that future research assess their validity before using
them in primary care settings, given that utilizing these measures in primary care was the
original intent in their creation.
In regards to the construction of the measures themselves, it is suggested that the
actual construction of individual items be revisited for future use. For example, many
items within the instruments are “double-barreled” with more than one query in each
item, such as “Stop using caffeine, alcohol, and tobacco products”. The problem with
“double-barreled” items is the fact that participants may choose their response based on
one part of the item, instead of all parts of the item. In this instance, a participant may
choose “Strongly agree” if they use caffeine and alcohol, but this neglects to address
tobacco products in the item if the participant does not use tobacco. Also, participants
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may have difficulty differentiating between scale anchors. For example, in the Treatment
Acceptability Scale differences between anchors such as “Slightly Effective”, “Unclear
Effectiveness”, and “Moderately Effective” may be difficult for respondents to
distinguish. To subjectively quantify the difference between whether a treatment is
slightly effective or moderately effective may prove to be an arduous task. Lastly,
because participants completed the Treatment Acceptability and Change questionnaires
during the same period of time, the response scales may have created incorrect
responding because the response scales were opposite of one another. In other words, the
Treatment Acceptability measure uses the first anchor as the most negative response
(“Not Effective at All”) and the Change Scale uses the first anchor as the most positive
response (“Strongly Agree”). From a visual perspective, the left to right placement of
anchors being opposite from one questionnaire to the next may have enabled erroneous
responding on behalf of participants.
Results of the current study demonstrated that pre-treatment insomnia outcomes,
treatment acceptability, and motivation for change did not predict improvement for
patients’ insomnia outcomes. These results can be accounted for by numerous limitations
such as a low response rate, small sample size, low power, and weak psychometric
properties of some measures. Future research should focus on refining test construction
of the three measures used as well as working to increase the sample size to provide a
more robust test of the study’s hypothesis.
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Appendix D
CONSENT FORM
Using a Computerized Self-Report Questionnaire to
Assess Sleep Disorders Presenting with Insomnia Symptoms
You are invited to join in a research study examining the usefulness of a questionnaire to
help diagnosis symptoms of insomnia. You were selected as a possible participant
because you described symptoms of insomnia, which include difficulty falling to sleep,
frequent nighttime awakenings sometimes with difficulty falling back to sleep, waking
too early and inability to return to sleep or feeling as though your sleep is poor quality.
We ask that you read this form and ask questions before agreeing to be in the study.
This study is being conducted by: Don Townsend, PhD, Con Iber, MD, Louis Kazaglis,
MD, from Fairview Health Systems and Shelby Afflerbach, BA of Minnesota State
University, Mankato.
Background Information
The purpose of this study is to determine whether a brief questionnaire that inquires about
various symptoms of insomnia can differentiate between different causes of insomnia.
Procedures:
If you agree to be in this study, we would ask that you complete a short, computerized
questionnaire in the office today and then again on the internet in about 2 weeks. The
questionnaire should take about 10 minutes to complete.
Risks and Benefits of being in the Study
The risks involved in this study are that you may feel uncomfortable answering questions
about your problems with insomnia.
There are no direct benefits to you for your participation. Your assistance will help us
learn whether this type of questionnaire can help distinguish between different sleep
problems that may look like insomnia but that need a different type of treatment.

Compensation: You will not receive any payment for participation in this study.
Confidentiality:
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Appendix D (continued)
The questionnaire is completed on the computer and your responses are stored on a
secure server. The only link between your name and the questionnaire is a unique ‘study
number’ assigned to you during participation. The reason we need your name and email
address is to send you an Internet link to complete the questionnaire a second time while
you are at home in about two weeks. We need to be able to match the two questionnaires
that you have completed. Any report we might publish from this information will not
include anything that will make it possible to identify you. Research records will be
stored at Fairview Sleep Clinics in a password-protected file and only researchers will
have access to the records. Study data will be stored on a secure server according to
current University policy for protection of confidentiality.
Voluntary Nature of the Study:
Participation in this study is voluntary. Your decision whether or not to participate will
not affect your current or future relations with Fairview Health System or the University
of Minnesota. If you decide to participate, you are free to withdraw at any time without
affecting those relationships.
Contacts and Questions:
The researchers conducting this study are: Don Townsend, PhD, Con Iber, MD, Louis
Kazaglis, MD, and Shelby Afflerbach, BA. You may ask any questions you have now. If
you have questions later, you are encouraged to contact Dr. Townsend at the Fairview
Brooklyn Park office at (763) 528-6985, (507) 398-5518 or with email at
dtownse4@fairview.org.
If you have any questions or concerns regarding this study and would like to talk to
someone other than the researchers, you are encouraged to contact the Research
Subjects’ Advocate Line, D528 Mayo, 420 Delaware St. Southeast, Minneapolis,
Minnesota 55455; (612) 625-1650.
You will be given a copy of this form at your request.
Statement of Consent:
I have read the above information. I know that I will not receive payment or
compensation for my participation in this study. I have had a chance to ask questions and
had my questions answered. I consent to participate in the study.
Participant Signature: ______________________________ Date: _____________
Office Staff Signature: ______________________________Date: _____________
Signature of Investigator: ____________________________Date: _____________
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Appendix E
Using a Computerized Self-Report Questionnaire to
Assess Sleep Disorders Presenting with Insomnia Symptoms
Primary Investigators: Don Townsend, PhD and Con Iber, MD

Do you experience difficulty sleeping?

Do you have difficulty falling or staying asleep?

If the answer is yes to either of these questions, then please help us with a project to learn
whether a computer program can help determine the possible underlying cause of your
sleep problem. Not everyone with sleep problems can see a sleep specialist for their
problem. We want to learn if people complete some questions on a computer whether the
computer can then suggest what the problem is and what the treatment options are.

Here is what we are asking you to do:
1. Complete a questionnaire on the computer today. It has 70 questions and takes
about 10 -15 minutes.
2. Provide an email address, if you have one, so that we can send you a link to the
questionnaire for you to complete a second time in about 2 weeks.
If you are willing to help with this project please let the receptionist or nurse know that
now. They will answer any questions that you have. Then we will need you to sign the
consent form that says you are willing to participate.

Don Townsend & Conrad Iber	
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Appendix F
Table 1
Overall Regression Model for Patient Improvement
Model
Sum of Squares
df
Mean Square
Regression
311.126
5
62.225
1 Residual
1025.541 21
48.835
Total
1336.667 26
Dependent Variable: PostTreatmentOutcomes
b. Predictors: (Constant), ChangeScaleReCoded,
Medical_Expert_Professional_Treatment, Medication_Treatment,
PreTreatmentOutcomes, Behavior_Modification_Treatment

F
1.274

Sig.
.312b

Table 2
Coefficients for Patient Improvement
Model

Unstandardized Standardized
t
Sig.
Coefficients
Coefficients
B
Std.
Beta
Error
(Constant)
-.695 17.039
-.041 .968
PreTreatmentOutcomes
.559
.275
.423 2.028 .055
Medication_Treatment
.003
.007
.076 .389 .701
1
Behavior_Modification_Treatment
1.159
2.268
.117 .511 .615
Medical_Expert_Professional_Treatment -.326
2.924
-.026 -.111 .912
ChangeScaleReCoded
.322
.431
.150 .746 .464
Dependent Variable: PostTreatmentOutcomes

INSOMNIA PATIENT IMPROVEMENT
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Figure 1. Patient improvement regression model
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